Skip to content
10-Q

Quarterly Report

Lazuriton Nano Biotechnology (U.S.A.) Inc.

0001640334-23-000452

← back to feed
Filed
Mar 27, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Mar 9, 2023 100M sh
Operating Cash Flow Q3 2021 · Sep 30, 2021 $0
Operating Cash Flow Q3 2021 · Sep 30, 2020 $1
Stockholders Equity Q3 2021 · Sep 30, 2021 −$350.63K
Stockholders Equity Q3 2021 · Jun 30, 2021 −$340.68K
Stockholders Equity Q3 2021 · Mar 31, 2021 −$330.73K
Stockholders Equity Q3 2021 · Dec 31, 2020 −$319.78K
Stockholders Equity Q3 2021 · Sep 30, 2020 −$300.83K
Stockholders Equity Q3 2021 · Jun 30, 2020 −$290.01K
Stockholders Equity Q3 2021 · Mar 31, 2020 −$279.99K
Stockholders Equity Q3 2021 · Dec 31, 2019 −$268.54K
Current Liabilities Q3 2021 · Sep 30, 2021 $351.98K
Current Liabilities Q3 2021 · Dec 31, 2020 $321.13K
Total Liabilities Q3 2021 · Sep 30, 2021 $351.98K
Total Liabilities Q3 2021 · Dec 31, 2020 $321.13K
Current Assets Q3 2021 · Sep 30, 2021 $1.35K
Current Assets Q3 2021 · Dec 31, 2020 $1.35K
Total Assets Q3 2021 · Sep 30, 2021 $1.35K
Total Assets Q3 2021 · Dec 31, 2020 $1.35K
Sga Expense Q3 2021 · Sep 30, 2021 $9.95K
Sga Expense Q3 2021 · Sep 30, 2021 $30.85K
Sga Expense Q3 2021 · Sep 30, 2020 $10.82K
Sga Expense Q3 2021 · Sep 30, 2020 $32.29K
Net Income Q3 2021 · Sep 30, 2021 −$9.95K
Net Income Q3 2021 · Sep 30, 2021 −$30.85K
Net Income Q3 2021 · Jun 30, 2021 −$9.95K
Net Income Q3 2021 · Mar 31, 2021 −$10.95K
Net Income Q3 2021 · Sep 30, 2020 −$10.82K
Net Income Q3 2021 · Sep 30, 2020 −$32.29K
Net Income Q3 2021 · Jun 30, 2020 −$10.02K
Net Income Q3 2021 · Mar 31, 2020 −$11.45K
Operating Income Q3 2021 · Sep 30, 2021 −$9.95K
Operating Income Q3 2021 · Sep 30, 2021 −$30.85K
Operating Income Q3 2021 · Sep 30, 2020 −$10.82K
Operating Income Q3 2021 · Sep 30, 2020 −$32.29K
Revenue Q3 2021 · Sep 30, 2021 $0
Revenue Q3 2021 · Sep 30, 2021 $0
Revenue Q3 2021 · Sep 30, 2020 $0
Revenue Q3 2021 · Sep 30, 2020 $0